SP245PROTEINURIA, NAG ACTIVITY, NGAL AND ALBUMIN ARE CAPABLE OF IDENTIFYING RISK OF DEVELOPING AKI IN PATIENTS UNDERGOING CHEMOTERAPIC TREATMENT | Publicación